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Background: Continuous axial flow left ventricular assist devices (LVAD) are designed to unload the left ventricle (LV) in patients with severe 
medically refractory heart failure secondary to LV systolic dysfunction. The effects of this therapy on the pulmonary circulation have not been clearly 
elucidated. We sought to define changes in pulmonary hemodynamics within the first year of LVAD implantation.
Methods: Echocardiography and Doppler were performed both prior and within one year after implantation of LVAD in 29 consecutive patients 
with severe heart failure. The following pulmonary hemodynamic indices were determined by Doppler based Methods: Pulmonary artery systolic 
pressure (PASP), mean pulmonary artery pressure (MPAP), pulmonary artery end-diastolic pressure (PAEDP) and pulmonary vascular resistance using 
the Abbas formula. New York Heart Association heart failure class was also recorded as an indicator of symptomatology.
Results: Pulmonary hemodynamic measurements were significantly reduced in combination with improvement in functional status after LVAD 
implantation (Table 1). 
Table 1. Change In Pulmonary Hemodynamics And Functional Status After LVAD Placement
Parameter Pre LVAD Post LVAD p value
PASP (mmHg) 60.7+/-16.5 33.5+/-11.5 5.7x10-9 (n=28)
MPAP (mmHg) 43.2+/-7.9 30.4+/-10 1.2x10-5 (n=29)
PAEDP (mmHg) 32.5+/-2.7 17.6+/-7.4 1.3x10-7 (n=22)
Pulmonary Vascular Resistance
(Wood units)
5.2+/-2.5 2.9+/-0.8 4.3x10-6 (n=28)
New York Heart Association 
Class<III (Number of patients)
0 16
Values are mean +/- 1 SD
Conclusions: Continuous flow LVAD significantly improves pulmonary hemodynamics and such effect was correlated with symptomatic 
improvement in patients with severe heart failure. This is likely related to a marked reduction in left atrial pressure from effective unloading of the LV 
and this early salutary effect represents a key benefit in the management of severe heart failure.
